Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Novel clinical trial designs emerging from the molecular reclassification of cancer

CA A Cancer Journal for Clinicians(2025)10.3322/caac.21880Source: DataRank Database

Novel clinical trial designs emerging from the molecular reclassification of cancer is a research paper published in CA A Cancer Journal for Clinicians (2025). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 5.51)OA: goldTopics (42)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (5)

Shumei Kato ORCID,Teresa Allen,Jason K. Sicklick ORCID,Razelle Kurzrock ORCID,Mina Nikanjam ORCID

Live enrichment

PubMed:39841128 PMC:PMC12061631 OpenAlex:https://openalex.org/W4406694225

NCI NIH HHS

Grant: U10 CA180888

NIH HHS

Grant: 5UG1CA233198-05

NCI NIH HHS

Grant: UG1 CA233198

NIH HHS

Grant: 5U01CA180888-08

FWCI

5.51

Citation Percentile

1.0%

Citation Trend

2025

2026

goldLicense: cc-by-nc-nd

journalhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.3322/caac.21880

publisherhttps://onlinelibrary.wiley.com/doi/pdfdirect/10.3322/caac.21880

publisherhttps://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21880

journalhttps://doi.org/10.3322/caac.21880

repositoryhttps://pubmed.ncbi.nlm.nih.gov/39841128

Fields of Study

Cancer Genomics and DiagnosticsLung Cancer Treatments and MutationsRadiomics and Machine Learning in Medical ImagingHumansNeoplasmsClinical Trials as TopicPrecision MedicineResearch DesignBiomarkers, TumorHigh-Throughput Nucleotide SequencingGenomics

MeSH Terms

Clinical Trials as TopicHumansNeoplasmsResearch DesignBiomarkers, TumorGenomicsPrecision MedicineHigh-Throughput Nucleotide Sequencing

Keywords

Clinical trialMedicinePrecision medicinePersonalized medicineBiomarker discoveryBiomarkerGenomicsPersonalizationDrug developmentDiseaseBioinformaticsComputational biologyDrugProteomicsInternal medicinePathologyComputer sciencePharmacologyGenomeBiologyCancerTissue AgnosticN‐of‐1

Novel clinical trial designs emerging from the molecular reclassification of cancer

FAIR Checklist

Authors (5)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)